A Novel Role of Peripheral Corticotropin-Releasing Hormone (CRH) on Dermal Fibroblasts
by Olga Rassouli, George Liapakis, Iakovos Lazaridis, George Sakellaris, Kostas Gkountelias, Achille Gravanis, Andrew N. Margioris, Katia P. Karalis, Maria Venihaki
Corticotropin-releasing hormone, or factor, (CRH or CRF) exerts important biological effects in multiple peripheral tissues via paracrine/autocrine actions. The aim of our study was to assess the effects of endogenous CRH in the biology of mouse and human skin fibroblasts, the primary cell type involved in wound healing. We show expression of CRH and its receptors in primary fibroblasts, and we demonstrate the functionality of fibroblast CRH receptors by induction of cAMP. Fibroblasts genetically deficient in Crh (Crh−/−) had higher proliferation and migration rates and compromised production of IL-6 and TGF-β1 compared to the wildtype (Crh+/+) cells. Human primary cultures of foreskin fibroblasts exposed to the CRF1 antagonist antalarmin recapitulated the findings in the Crh−/− cells, exhibiting altered proliferative and migratory behavior and suppressed production of IL-6. In conclusion, our findings show an important role of fibroblast-expressed CRH in the proliferation, migration, and cytokine production of these cells, processes associated with the skin response to injury. Our data suggest that the immunomodulatory effects of CRH may include an important, albeit not explored yet, role in epidermal tissue remodeling and regeneration and maintenance of tissue homeostasis.
For the full article visit: A Novel Role of Peripheral Corticotropin-Releasing Hormone (CRH) on Dermal Fibroblasts
Syndicated from:PLoS ONE
Article is licensed under a Creative Commons Attribution License.